CNTG News and Press, Centogene N.V. From 03/30/22

Image source: The Motley Fool. Centogene N.V. (NASDAQ: CNTG) Q4 2021 Earnings Call Mar 30, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Centogene N.V. (CNTG) Q4 2021 Earnings Call Transcript

Centogene N.V. (CNTG) Q4 2021 Earnings Conference Call March 30, 2022, 8:00 AM ET Company Participants Kim Stratton – Chief Executive Officer Miguel Coego Rios – Chief Financial Officer Bettina Goerner – Chief Data Officer Maximilian Schmid – Chief Commercial Offic...

Centogene press release (NASDAQ:CNTG): Q4 Net loss of €12.3M Revenue of €42.9M (-39.0% Y/Y). Shares +4.95% PM. For further details see: Centogene reports Q4 results

- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million Financing Round and on Track to Exit COVID-19 Business - Management...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 24, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that CEO Kim Stratton will speak at the...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial r...

Centogene N.V. (NASDAQ:CNTG), a German biotech focused on rare disorders, announced on Thursday that the company agreed to expand its data access and collaboration agreement with the U.S. pharma giant Pfizer (PFE). In 2019, the two companies signed an initial agreement to identify and validat...

In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical targets for the potential development of new therapies for rare diseases New research phase aims to substantiate earlier ...

MBMV invests in international bio-tech startup Arcensus GmbH Hoboken, NJ, Rostock/Berlin, Germany, Feb 22, 2022 - (ACN Newswire) - Based on Whole Genome Sequencing (WGS), Arcensus GmbH makes it possible to detect rare as well as frequent disorders such as cancer or heart disea...

Centogene (NASDAQ:CNTG) plans for the transition of CFO René Just and the appointment of Miguel Coego Rios as EVP, Finance & Legal and Interim CFO. René Just has resigned effective Mar.31, 2022 post filing of the company's annual report; Miguel Coeg...